New Treatment for Autoimmune Diseases? (All-Natural!)
Autoimmune disease occurs when your body attacks its own tissues.
The specific condition you have—and the symptoms you’re living with—will be based on which part of your body your immune system is attacking.
However, whether you’re suffering from multiple sclerosis, rheumatoid arthritis (RA), lupus, ankylosing spondylitis, or something else—most autoimmune diseases tend to have two things in common: inflammation and pain.
That’s why most treatments focus on ways to reduce these factors.
But long before Big Pharma came along, Nature was already on the case…
The herb ginger has many proven health benefits, from treating nausea and motion sickness to benefitting anxiety and depression.
And now, we can add treating autoimmune disease to the list.
Many autoimmune diseases have overactive neutrophils, a type of white blood cell.
Well, ginger helps calm this overactive response.
In a clinical trial, participants took a ginger supplement daily (20 mg of gingerols) for a week.
The research revealed ginger restrained the formation of neutrophil extracellular trap (NET), web-like structures that trigger inflammation and clotting.
NETs contribute to the development of autoimmune diseases like lupus and RA.
Ginger is already well-known for its potent anti-inflammatory effect, but this study helps explain how it works.
It ALSO highlights ginger’s value as a potential treatment for autoimmune disease.
Who knows how long the scientific community will twiddle their thumbs, deciding whether or not to officially recommend ginger as a treatment.
But in the meantime, you can act NOW and talk to your doctor about adding ginger to your personal treatment plan.
P.S. Your best bet is to never get an autoimmune disease in the first place. And you can do that by taking two supplements shown to significantly reduce your risk. CLICK HERE for all the exciting details.
SOURCE:
Ramadan A. Ali, et al., “Ginger intake suppresses neutrophil extracellular trap formation in autoimmune mice and healthy humans,” JCI insight, Open access, 9.22.23, 10.1172/jci.insight.172011
